Compounds > imipenem, anhydrous
Page last updated: 2024-08-26

imipenem, anhydrous and Cholera Infantum

imipenem, anhydrous has been researched along with Cholera Infantum in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's3 (50.00)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barie, PS; Dellinger, EP; Grasela, TH; Rotstein, OD; Walawander, CA1
Caviezel, A; Garbino, J; Lew, D; Matulionyte, R; Morel, P; Uckay, I; Villiger, P1
Chloroyiannis, J; Giamarellou, H; Kanellakopoulou, K; Papadothomakos, P; Sfikakis, P; Theakou, R; Tsipras, H1
Barie, PS; Baumgartner, TF; Dellinger, EP; Rotstein, OD; Solomkin, JS; Vogel, SB; Yang, JY1
Faulkner, K; Wilson, SE1
Aziz, M; Brown, KR; Calandra, GB; Wang, C1

Trials

4 trial(s) available for imipenem, anhydrous and Cholera Infantum

ArticleYear
A randomized prospective study of cefepime plus metronidazole with imipenem-cilastatin in the treatment of intra-abdominal infections.
    Infection, 2007, Volume: 35, Issue:3

    Topics: Abdominal Cavity; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Bacterial Infections; Cefepime; Cephalosporins; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Hospitals, University; Humans; Imipenem; Male; Metronidazole; Middle Aged

2007
Meropenem versus imipenem/cilastatin in the treatment of intraabdominal infections requiring surgery.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1993, Volume: 12, Issue:6

    Topics: Adult; Aged; Cilastatin; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Imipenem; Male; Meropenem; Middle Aged; Peritonitis; Prospective Studies; Thienamycins; Treatment Outcome

1993
A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group.
    Archives of surgery (Chicago, Ill. : 1960), 1997, Volume: 132, Issue:12

    Topics: Abdomen; Abdominal Abscess; Adult; Aged; Antitrichomonal Agents; Appendicitis; Cefepime; Cephalosporins; Cilastatin; Double-Blind Method; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Imipenem; Infections; Male; Metronidazole; Middle Aged; Peritonitis; Treatment Outcome

1997
Impact an anatomical site on bacteriological and clinical outcome in the management of intra-abdominal infections.
    The American surgeon, 1998, Volume: 64, Issue:5

    Topics: Adult; Aged; Anti-Bacterial Agents; Appendicitis; Bacterial Infections; Bacteriological Techniques; Cause of Death; Cilastatin; Clindamycin; Combined Modality Therapy; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Imipenem; Male; Meropenem; Middle Aged; Peritonitis; Risk Factors; Survival Rate; Thienamycins; Tobramycin; Treatment Outcome

1998

Other Studies

2 other study(ies) available for imipenem, anhydrous and Cholera Infantum

ArticleYear
The cost-effectiveness of cefepime plus metronidazole versus imipenem/cilastatin in the treatment of complicated intra-abdominal infection.
    Surgical infections, 2004,Fall, Volume: 5, Issue:3

    Topics: Adult; Aged; APACHE; Bacterial Infections; Cefepime; Cephalosporins; Cilastatin; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Diseases; Humans; Imipenem; Male; Metronidazole; Middle Aged; Probability; Retrospective Studies; Treatment Outcome

2004
The safety profile of imipenem/cilastatin: worldwide clinical experience based on 3470 patients.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 18 Suppl E

    Topics: Bacterial Infections; Blood Cell Count; Cilastatin; Cyclopropanes; Dipeptidases; Gastrointestinal Diseases; Humans; Imipenem; Thienamycins

1986